These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 18187113)

  • 21. Effectiveness of standardized nursing care plans to achieve A1C, blood pressure, and LDL-C goals among people with poorly controlled type 2 diabetes mellitus at baseline: four-year follow-up study.
    Cárdenas-Valladolid J; López-de Andrés A; Jiménez-García R; de Dios-Duarte MJ; Gómez-Campelo P; de Burgos-Lunar C; San Andrés-Rebollo FJ; Abánades-Herranz JC; Salinero-Fort MA
    BMC Fam Pract; 2018 Jul; 19(1):125. PubMed ID: 30041600
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Control of cardiovascular risk factors in patients with diabetes and hypertension at urban academic medical centers.
    McFarlane SI; Jacober SJ; Winer N; Kaur J; Castro JP; Wui MA; Gliwa A; Von Gizycki H; Sowers JR
    Diabetes Care; 2002 Apr; 25(4):718-23. PubMed ID: 11919131
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardiac risk factors: new cholesterol and blood pressure management guidelines.
    Anthony D; George P; Eaton CB
    FP Essent; 2014 Jun; 421():28-43. PubMed ID: 24936717
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of icosapent ethyl on lipid and inflammatory parameters in patients with diabetes mellitus-2, residual elevated triglycerides (200-500 mg/dL), and on statin therapy at LDL-C goal: the ANCHOR study.
    Brinton EA; Ballantyne CM; Bays HE; Kastelein JJ; Braeckman RA; Soni PN
    Cardiovasc Diabetol; 2013 Jul; 12():100. PubMed ID: 23835245
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cultural competency training and performance reports to improve diabetes care for black patients: a cluster randomized, controlled trial.
    Sequist TD; Fitzmaurice GM; Marshall R; Shaykevich S; Marston A; Safran DG; Ayanian JZ
    Ann Intern Med; 2010 Jan; 152(1):40-6. PubMed ID: 20048271
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum Lipids and Proliferative Diabetic Retinopathy and Macular Edema in Persons With Long-term Type 1 Diabetes Mellitus: The Wisconsin Epidemiologic Study of Diabetic Retinopathy.
    Klein BE; Myers CE; Howard KP; Klein R
    JAMA Ophthalmol; 2015 May; 133(5):503-10. PubMed ID: 25502808
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reduction of new coronary events and new atherothrombotic brain infarction in older persons with diabetes mellitus, prior myocardial infarction, and serum low-density lipoprotein cholesterol >/=125 mg/dl treated with statins.
    Aronow WS; Ahn C; Gutstein H
    J Gerontol A Biol Sci Med Sci; 2002 Nov; 57(11):M747-50. PubMed ID: 12403804
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Outpatient electronic health records and the clinical care and outcomes of patients with diabetes mellitus.
    Reed M; Huang J; Graetz I; Brand R; Hsu J; Fireman B; Jaffe M
    Ann Intern Med; 2012 Oct; 157(7):482-9. PubMed ID: 23027319
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of simvastatin on the lipid profile and attainment of low-density lipoprotein cholesterol goals when added to thiazolidinedione therapy in patients with type 2 diabetes mellitus: A multicenter, randomized, double-blind, placebo-controlled trial.
    Lewin AJ; Kipnes MS; Meneghini LF; Plotkin DJ; Perevozskaya IT; Shah S; Maccubbin DL; Mitchel YB; Tobert JA;
    Clin Ther; 2004 Mar; 26(3):379-89. PubMed ID: 15110130
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of atorvastatin versus fenofibrate on lipoprotein profiles, low-density lipoprotein subfraction distribution, and hemorheologic parameters in type 2 diabetes mellitus with mixed hyperlipoproteinemia.
    Frost RJ; Otto C; Geiss HC; Schwandt P; Parhofer KG
    Am J Cardiol; 2001 Jan; 87(1):44-8. PubMed ID: 11137832
    [TBL] [Abstract][Full Text] [Related]  

  • 31. All-cause mortality in patients with type 2 diabetes in association with achieved hemoglobin A(1c), systolic blood pressure, and low-density lipoprotein cholesterol levels.
    Chiang HH; Tseng FY; Wang CY; Chen CL; Chen YC; See TT; Chen HF
    PLoS One; 2014; 9(10):e109501. PubMed ID: 25347712
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Incidence of new atherothrombotic brain infarction in older persons with prior myocardial infarction and serum low-density lipoprotein cholesterol >or=125 mg/dl treated with statins versus no lipid-lowering drug.
    Aronow WS; Ahn C; Gutstein H
    J Gerontol A Biol Sci Med Sci; 2002 May; 57(5):M333-5. PubMed ID: 11983729
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Temporal trends in optimal diabetic care and complications of elderly type 2 diabetes patients in Thailand: A nationwide study.
    Kaewput W; Thongprayoon C; Mungthin M; Jindarat S; Varothai N; Suwannahitatorn P; Rangsin R; Mao MA; Cheungpasitporn W
    J Evid Based Med; 2019 Feb; 12(1):22-28. PubMed ID: 30398014
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Atorvastatin lowers plasma low-density lipoprotein cholesterol and C-reactive protein in Japanese type 2 diabetic patients.
    Yamada S; Yanagawa T; Sasamoto K; Araki A; Miyao M; Yamanouchi T
    Metabolism; 2006 Jan; 55(1):67-71. PubMed ID: 16324921
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diabetes, hemoglobin A(1c), cholesterol, and the risk of moderate chronic renal insufficiency in an ambulatory population.
    Hsu CY; Bates DW; Kuperman GJ; Curhan GC
    Am J Kidney Dis; 2000 Aug; 36(2):272-81. PubMed ID: 10922305
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Simultaneous control of diabetes mellitus, hypertension, and hyperlipidemia in 2 health systems.
    Schroeder EB; Hanratty R; Beaty BL; Bayliss EA; Havranek EP; Steiner JF
    Circ Cardiovasc Qual Outcomes; 2012 Sep; 5(5):645-53. PubMed ID: 22851534
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum lipids and glucose control: the SEARCH for Diabetes in Youth study.
    Petitti DB; Imperatore G; Palla SL; Daniels SR; Dolan LM; Kershnar AK; Marcovina S; Pettitt DJ; Pihoker C;
    Arch Pediatr Adolesc Med; 2007 Feb; 161(2):159-65. PubMed ID: 17283301
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence and phenotypic distribution of dyslipidemia in type 1 diabetes mellitus: effect of glycemic control.
    Pérez A; Wägner AM; Carreras G; Giménez G; Sánchez-Quesada JL; Rigla M; Gómez-Gerique JA; Pou JM; de Leiva A
    Arch Intern Med; 2000 Oct; 160(18):2756-62. PubMed ID: 11025785
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adequacy of control of hypertension in an academic nursing home.
    Koka M; Joseph J; Aronow WS
    J Am Med Dir Assoc; 2007 Oct; 8(8):538-40. PubMed ID: 17931579
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Peroxisome proliferator-activated receptor-gamma agonist increases both low-density lipoprotein cholesterol particle size and small high-density lipoprotein cholesterol in patients with type 2 diabetes independent of diabetic control.
    Bavirti S; Ghanaat F; Tayek JA
    Endocr Pract; 2003; 9(6):487-93. PubMed ID: 14715475
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.